Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Guidelines for the Clinical Management of HIV/AIDS - Tanzania (NACP; 2005; 131 pages)
View the documentLIST OF ABBREVIATIONS
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
Open this folder and view contentsCHAPTER 1: INTRODUCTION
Open this folder and view contentsCHAPTER 2: ORGANIZATION OF HIV/AIDS CARE AND TREATMENT
Open this folder and view contentsCHAPTER 3: HIV/AIDS PREVENTION
Open this folder and view contentsCHAPTER 4: PROTECTIVE MEASURES AGAINST HIV TRANSMISSION
Open this folder and view contentsCHAPTER 5: LABORATORY TESTS IN HIV/AIDS
Open this folder and view contentsCHAPTER 6: HIV/AIDS AND PREGNANCY
Open this folder and view contentsCHAPTER 7: PEDIATRIC HIV/AIDS AND RELATED CONDITIONS
Open this folder and view contentsCHAPTER 8: COMMUNITY AND HOME BASED CARE FOR PEOPLE LIVING WITH HIV/AIDS (PLHA)
Open this folder and view contentsCHAPTER 9: COUNSELLING RELATED TO HIV-TESTING AND TREATMENT ADHERENCE
Open this folder and view contentsCHAPTER 10: MANAGEMENT OF COMMON SYMPTOMS AND OPPORTUNISTIC INFECTIONS IN HIV/AIDS
Open this folder and view contentsCHAPTER 11: MANAGEMENT OF MENTAL HEALTH PROBLEMS IN HIV/AIDS
Open this folder and view contentsCHAPTER 12: MANAGEMENT OF HIV INFECTED PATIENTS USING ANTIRETROVIRAL DRUGS
Open this folder and view contentsCHAPTER 13: ARV THERAPY IN INFANTS AND CHILDREN
close this folderCHAPTER 14: USE OF ARVS IN SPECIAL CIRCUMSTANCES
Open this folder and view contents14.1 People with tuberculosis disease and HIV co-infection
close this folder14.2 Post Exposure Prophylaxis-(PEP)
View the document14.2.1 Occupational exposure
View the document14.2.2 Treatment of an Exposure Site
View the document14.2.3 Exposure Report
View the document14.2.4 Evaluation of the Exposed HCW
View the document14.2.5 Drugs for PEP for HIV
View the document14.2.6 Timing of Post Exposure prophylaxis(PEP)
View the document14.2.7 Duration of Post Exposure Prophylaxis(PEP)
View the document14.2.8 Follow-up of Health care worker Exposed to HIV
View the document14.2.9 Monitoring and Management of PEP Toxicity
Open this folder and view contents14.3 HIV PEP in men and women who have been raped/sexually assaulted
Open this folder and view contentsCHAPTER 15: HIV/AIDS AND NUTRITION
Open this folder and view contentsCHAPTER 16: MANAGEMENT OF ANTIRETROVIRAL MEDICINES
Open this folder and view contentsCHAPTER 17: CERTIFICATION OF HEALTHCARE FACILITIES AS CARE AND TREATMENT SITES
 

14.2.4 Evaluation of the Exposed HCW

Health care worker exposed to HIV should be evaluated within hours (rather than days) after their exposure in order to allow early initiation of PEP. The exposed Health care workers should be counselled and tested for HIV at baseline (i.e., to establish infection status at the time of exposure). In case of refusal to test, PEP should not be started or should be discontinued. For purposes of considering HIV PEP, the evaluation also should include information about medications the exposed person might be taking and any current or underlying medical conditions or circumstances (i.e., pregnancy, breast feeding, or renal or hepatic disease) that might influence drug selection. Hepatitis B vaccination should be considered after any large volume needle-stick injury.

to previous sectionto next section

Please provide your feedback English  |  French